A study of the effects of fasting and supplementation on glucose and lipid metabolism

Not Applicable

• Conditions: Healthy Adults

• Registration Number: JPRN-UMIN000050667
• Lead Sponsor: Akasaka Family Clinic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-24
• Study Completion: 2023-05-22
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

Not provided

Exclusion Criteria

1) Persons who are currently suffering from some kind of disease and are judged by the investigator to need treatment 2) Persons with a history or current illness of severe disorders including liver, kidney, heart, lung, blood, digestive system, etc. 3) Persons with alcohol dependence or other mental disorders 4) Persons with a habit of taking medication for treatment of illness within the past month (excluding occasional use of medication for headache, menstrual pain, cold, etc.) 5) Persons who may develop seasonal allergy symptoms during the trial period, specific allergens include: Hanoki, Oobayashabushi, birch, sugi, hinoki, ragweed, mugwort, orchardgrass, and timothy grass 6) Persons who may experience allergic reactions to the ingredients in the test food, or those who may experience severe allergic reactions to other food or medication 7) Persons with severe anemia 8) Persons prone to contact dermatitis, those who have had it in the past, or those with sensitive fingertips 9) Persons who have a smoking habit 10) Women who are pregnant, nursing, planning to become pregnant during the trial period, or planning to become pregnant during the trial period 11) Persons who may change their lifestyle during the trial period (e.g., night shift work, long-term travel, etc.) 12) Persons who have habitually consumed functional food, health food, supplements containing ingredients of the test food within the past 3 months or plan to consume them during the trial period. 13) Persons who have received treatment requiring hospitalization within the past 6 months. 14) Persons who participate in other clinical studies or participated in the last 3 months or plan to participate in other clinical studies. 15) Persons who are judged by the investigator to be inappropriate for this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified